Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Biochem J ; 387(Pt 3): 773-8, 2005 May 01.
Article in English | MEDLINE | ID: mdl-15554876

ABSTRACT

Two mutations (G8363A and A8296G) in the mtDNA (mitochondrial DNA) tRNA(Lys) gene have been associated with severe mitochondrial diseases in a number of reports. Their functional significance, however, remains unknown. We have already shown that homoplasmic cybrids harbouring the A8296G mutation display normal oxidative phosphorylation, although the possibility of a subtle change in mitochondrial respiratory capacity remains an open issue. We have now investigated the pathogenic mechanism of another mutation in the tRNA(Lys) gene (G8363A) by repopulating an mtDNA-less human osteosarcoma cell line with mitochondria harbouring either this genetic variant alone or an unusual combination of the two mutations (A8296G+G8363A). Cybrids homoplasmic for the single G8363A or the A8296G+G8363A mutations have defective respiratory-chain enzyme activities and low oxygen consumption, indicating a severe impairment of the oxidative phosphorylation system. Generation of G8363A cybrids within a wild-type or the A8296G mtDNA genetic backgrounds resulted in an important alteration in the conformation of the tRNA(Lys), not affecting tRNA steady-state levels. Moreover, mutant cybrids have an important decrease in the proportion of amino-acylated tRNA(Lys) and, consequently, mitochondrial protein synthesis is greatly decreased. Our results demonstrate that the pathogenicity of the G8363A mutation is due to a change in the conformation of the tRNA that severely impairs aminoacylation in the absence of changes in tRNA stability. The only effect detected in the A8296G mutation is a moderate decrease in the aminoacylation capacity, which does not affect mitochondrial protein biosynthesis.


Subject(s)
Gene Expression Regulation/genetics , Mitochondria/metabolism , RNA, Transfer, Lys/genetics , Aminoacylation , Cell Line, Tumor , DNA, Mitochondrial/genetics , Humans , MERRF Syndrome/genetics , MERRF Syndrome/physiopathology , Mutation , Phenotype , Protein Conformation , RNA, Transfer, Lys/physiology
2.
Nucleic Acids Res ; 30(9): 1985-90, 2002 May 01.
Article in English | MEDLINE | ID: mdl-11972336

ABSTRACT

Base insertion mutations in the anticodons of two different Escherichia coli tRNAs have been isolated that allow suppression of a series of +1 frameshift mutations. Insertion of a U between positions 34 and 35 of tRNAGln1 or addition of a G between positions 36 and 37 of tRNA(Lys) expand the anticodons of both tRNAs similarly to 3'-GUUU(-5') and allow decoding of complementary 5'-CAAA(-3') quadruplets. Analysis of the suppressed mRNA sequences suggests that suppression occurs by pairing of the expanded anticodons to all four bases of the complementary, quadruplet codon. The tRNA Gln mutants are identical to the sufG class of frameshift suppressors isolated both in Salmonella enterica serovar Typhimurium and E. coli by Kohno and Roth and previously thought to affect tRNA(Lys).


Subject(s)
Escherichia coli/genetics , Frameshift Mutation , RNA, Transfer, Gln/chemistry , RNA, Transfer, Gln/physiology , RNA, Transfer, Lys/chemistry , RNA, Transfer, Lys/physiology , Anticodon , Base Sequence , Chromosome Mapping , Codon , Genes, Bacterial , Genes, Suppressor , Models, Genetic , Molecular Sequence Data , Mutagenesis, Insertional , Nucleic Acid Conformation , RNA, Bacterial/chemistry , RNA, Bacterial/genetics , RNA, Transfer, Gln/genetics , RNA, Transfer, Lys/genetics , Salmonella/genetics
3.
Virology ; 257(1): 95-105, 1999 Apr 25.
Article in English | MEDLINE | ID: mdl-10208924

ABSTRACT

HIV-1 virions contain approximately equal amounts of tRNALys,3 and tRNALys1,2, yet tRNALys,3 has been found to be exclusively used for initiation of reverse transcription. Since previous studies have shown that even if the primer binding site (PBS) was mutated to be complementary to tRNALys1,2, the virus did not stably use tRNALys1,2 to initiate reverse transcription, the virus must have evolved a mechanism for the exclusive use of tRNALys,3 to initiate reverse transcription. To investigate how HIV-1 discriminates tRNALys1,2 from tRNALys,3 for initiation of reverse transcription, two proviral genomes that contain nucleotide changes in U5 and a PBS to be complementary to regions of tRNALys1,2 were constructed. One genome contains 5 [HXB2(L12-AC)] nucleotides while another contains 15 [HXB2(L12-ACgg)] nucleotides in U5 complementary to the anticodon region of tRNALys1,2. Viruses derived from the transfection of the proviral genomes were infectious in SupT1 cells. Analysis of the endogenous reverse transcription reactions from viruses derived from HXB2 (L12-AC) and HXB2 (L12-ACgg) obtained from transfection revealed that both exclusively used tRNALys1,2 to initiate reverse transcription. Following extensive in vitro culture, though, sequence analysis of proviral genomes revealed that while the virus derived from HXB2(L12-AC) stably maintained a PBS complementary to tRNALys1,2, the virus derived from HXB2 (L12-ACgg) had reverted back to contain a PBS complementary to tRNALys,3. RNA modeling of the U5-PBS of the genome from HXB2(L12-AC) supports the conclusion that the fine specificity for discrimination between tRNALys,3 and tRNALys1,2 for use as a primer for HIV-1 reverse transcription resides in the structure of the U5-PBS region of the viral genome.


Subject(s)
HIV-1/genetics , RNA, Transfer, Amino Acyl/physiology , RNA, Transfer, Lys/physiology , RNA, Viral/physiology , Transcription, Genetic , Animals , Base Sequence , COS Cells , Humans , Molecular Sequence Data , Nucleic Acid Conformation , Proviruses/genetics
4.
Biochemistry ; 37(40): 14189-94, 1998 Oct 06.
Article in English | MEDLINE | ID: mdl-9760256

ABSTRACT

There is a lack of correlation between biochemical studies and the observed clinical resistance of AIDS patients on long-term AZT therapy. Mutant HIV-1 reverse transcriptase in the viral isolates from these patients shows a 100-fold decrease in sensitivity to AZT whereas little or no difference is observed in kinetic parameters in vitro using steady-state kinetic analysis. A pre-steady-state kinetic analysis was used to examine the binding and incorporation of 2'-deoxythymidine 5'-triphosphate (dTTP) and 3'-azido-3'-deoxythymidine 5'-triphosphate (AZTTP) by wild-type HIV-1 reverse transcriptase and a clinically important AZT-resistant mutant form of the enzyme (D67N, K70R, T215Y, K219Q) utilizing a physiologically relevant RNA 18-mer/RNA 36-mer primer-template substrate. It was determined that with this RNA/RNA substrate there is a 2.6-fold increase in the selection for incorporation of the natural nucleotide dTTP over the unnatural nucleoside analogue AZTTP by AZT-resistant reverse transcriptase as compared to its wild-type form. This observation indicates that the tRNALys initiation step plays an important role in the development of drug resistance. Furthermore, this result implies that the structural basis of AZT resistance in HIV-1 reverse transcriptase involves the conformation of the RNA-DNA junction (formed upon attachment of a deoxynucleotide to the RNA primer). Taken together, these observations suggest a new pharmacological basis for the development of more effective and novel AIDS drugs.


Subject(s)
HIV Reverse Transcriptase/genetics , HIV-1/enzymology , Peptide Chain Initiation, Translational/physiology , RNA, Transfer, Lys/physiology , Zidovudine/pharmacology , DNA Primers/metabolism , DNA, Viral/drug effects , Dideoxynucleotides , Drug Resistance, Microbial , HIV-1/genetics , Humans , Kinetics , RNA/metabolism , RNA, Transfer, Lys/metabolism , Templates, Genetic , Thymine Nucleotides/metabolism , Virus Replication/drug effects , Zidovudine/analogs & derivatives , Zidovudine/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...